What is the first-line treatment and necessary initial testing for a newly diagnosed child with Graves disease?

First-Line Treatment for Newly Diagnosed Pediatric Graves' Disease

Start carbimazole or methimazole (thiamazole) at 0.4-0.8 mg/kg/day (0.3-0.6 mg/kg/day for methimazole), up to a maximum of 30 mg daily, with the dose titrated based on disease severity. 1

Initial Medication Dosing

• Moderate disease (free T4 <50 pmol/L): Use 0.4 mg/kg/day
• Severe disease (free T4 >70 pmol/L): Use 0.8 mg/kg/day
• Administer once daily for better compliance, though twice daily dosing is acceptable 1

Critical: Propylthiouracil is absolutely contraindicated in children due to higher hepatotoxicity risk 1

Adjunctive Therapy for Severe Symptoms

If the child has severe or poorly tolerated tachycardia, add beta-blockers for the first 2-4 weeks:

• Atenolol: 1-2 mg/kg once daily, OR
• Propranolol: 1-2 mg/kg divided into 2-3 doses daily 1

Continue beta-blockers only until thyroid hormone normalization is achieved.

Required Initial Testing

Before starting antithyroid drugs, obtain:

1. Complete blood count (CBC) - Useful to establish baseline neutrophil count, as hyperthyroidism itself can cause mild neutropenia 1

2. Transaminases (liver enzymes) - Baseline liver function before initiating treatment 1

3. Free T4, Free T3, and TSH - Already done for diagnosis, but document baseline severity 1

Note: Systematic CBC and liver function monitoring during follow-up is NOT required unless symptoms develop 1

Monitoring Schedule

• Week 2: Check free T4, free T3, TSH, and assess drug tolerance
• Week 4: Repeat thyroid function tests
• Monthly thereafter until TSH normalizes (can take 2-6 weeks for euthyroidism) 1
• Once TSH normalized: Quarterly monitoring with TSH only 1

Critical Safety Monitoring

Perform emergency CBC if the child develops:

• Fever
• Sore throat/angina 1

Action if neutrophils <1000/mm³: Discontinue or decrease antithyroid drug; may be permanently contraindicated if severe (<500) and persistent 1

Check liver enzymes emergently if:

• Jaundice
• Digestive disorders
• Pruritus 1

Treatment Duration and Expectations

Plan for prolonged treatment: 3-6 years minimum 1. This is longer than adults and critical for success:

• Remission rate after 2 years: Only ~30% in children (vs. 40-60% in adults) 1
• Relapse risk is higher in children, particularly with:
  • Young age at diagnosis
  • Large goiter
  • Severe initial disease (high T4, high TSH receptor antibodies)
  • Non-Caucasian ethnicity 1, 2

Once euthyroid, gradually reduce dose by 30-50% to maintenance of 5-15 mg/day 1

Important Pitfalls to Avoid

1. Do NOT use "block and replace" regimen (high-dose antithyroid drug + levothyroxine) - no benefit and increases side effects 1

2. Do NOT stop treatment prematurely - longer initial treatment courses decrease relapse risk 2

3. Educate families upfront that only 50% achieve remission after several years of medical treatment; radical treatment (radioactive iodine or thyroidectomy) may ultimately be needed 1

4. Watch for minor side effects (urticaria, arthralgia, rashes) in 5-25% of children - these are usually transient and most can continue treatment 1

5. Beware of false hyperthyroidism if child is taking biotin supplements (can interfere with lab assays) 1

Specialist Referral

This child should be managed by a pediatric endocrinologist experienced in treating childhood thyroid disorders 1. The complexities of prolonged treatment, higher relapse rates, and need for careful monitoring warrant specialist care.